Abstract
It is still controversial whether the identification of micrometastases and isolated tumor cells in the axillary lymph nodes of patients with breast cancer has any prognostic value. We evaluated the prognostic role of isolated tumor cells and micrometastases in the axillary lymph nodes in 3,158 consecutive patients pT1-2 pN0-N1mi (with a single involved lymph node) and M0, referred to the Division of Medical Oncology after surgery performed at the European Institute of Oncology from April 1997 to December 2002. Median follow-up was 6.3 years (range 0.1–11 years). Sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) were performed in 2,087 and 1,071 patients, respectively. A worse metastasis-free survival was observed for patients with micrometastatic disease compared to node-negative patients, if staged with ALND (log-rank P < .0001; HR: 3.17; 95% CI 1.72–5.83 at multivariate analysis), but not for patients who underwent SLNB (log-rank P = 0.36). The presence of a single micrometastatic lymph node is associated with a higher risk of distant recurrence as compared to node-negative disease only for patients undergoing ALND for staging purposes. Treatment recommendations for systemic therapy should not take into account the presence of a single micrometastatic lymph node identified during complete serial sectioning of sentinel node(s).
Similar content being viewed by others
References
Colleoni M, Rotmensz N, Perruzzotti G et al (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379–1389
International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335:1565–1568
Truong PT, Vinh-Hung V, Cserni G et al (2008) The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 44(12):1670–1677
Chen SL, Hoehne FM (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Sur Oncol 14(12):3378–3384
van der Heiden-van der Loo M, Bezemer PD, Hennipman A et al (2006) Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32:710–714
van Rijk MC, Peterse JL, Nieweg OE et al (2006) Additional axillary metastases or submicrometastases in sentinel lymph nodes. Cancer 107(3):467–471
Tjan-Heijnen VC, Bult P, de Widt-Evert LM et al (2001) Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70(2):81–88
Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864–1867
Elston CW, Ellis IO (2002) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer-Experience from a large study with long-term follow-up. Histopathology 41:151
Rosen PP, Oberman H (1993) Tumors of the mammary gland. Armed Forces Institute of Pathology, Washington
Colleoni M, Orvieto E, Nolè F et al (1999) Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer 35:574–579
Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20:3628–3636
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553
Gennari R, Curigliano G, Rotmensz N et al (2004) Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 101:1302–1310
Goldhirsch A, Wood WC, Senn HJ et al (1995) Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. J Natl Cancer Inst 87:1441–1445
Goldhirsch A, Glick JH, Gelber RD et al (1998) Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601–1608
Colleoni M, Liman HJ, Castiglione-Gertsch M et al (2002) Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF. Br J Cancer 86:1705–1714
Fisher B, Brown AM, Dimitrov NV et al (1990) Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B 15. J Clin Oncol 8:1483–1496
Huvos AG, Hutter R (1971) Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173:44–46
Saphir O, Amromin GD (1948) Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1:238–241
Hainsworth PJ, Tjandra JJ, Stillwell RG et al (1993) Detection and significance of occult metastases in node negative breast cancer. Br J Surg 80:459–463
Hansen MN, Grube BJ, Te W et al (2001) Clinical significance of axillary micrometastases in breast cancer: how small is too small? Proc Am Soc Clin Oncol 20:24 abstr 91
De Boer M, van Deurzen CH, van Dijck JA et al. (2009) Micrometastases and isolated tumors cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists group (BOOG). Cancer Res 69(Suppl 2):70s abstr 23
Gobardhan PD, Elias SG, Madsen EVE et al (2009) Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol 20(1):41–48
Acknowledgments
We thank the patients, nurses and physicians at the European Institute of Oncology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Montagna, E., Viale, G., Rotmensz, N. et al. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat 118, 385–394 (2009). https://doi.org/10.1007/s10549-009-0446-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-009-0446-6